Total Payments
$1,142
2024 Payments
$189.74
Companies
20
Transactions
37
Medicare Patients
7,388
Medicare Billing
$567,721
Payment Breakdown by Category
Food & Beverage$1,142 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,142 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Coloplast Corp | $206.17 | 1 | $0 (2018) |
| PROCEPT BioRobotics Corporation | $189.74 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $137.94 | 7 | $0 (2021) |
| C. R. Bard, Inc. & Subsidiaries | $109.55 | 1 | $0 (2017) |
| Laborie Medical Technologies Corp. | $67.57 | 1 | $0 (2021) |
| PFIZER INC. | $63.94 | 5 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $63.23 | 1 | $0 (2018) |
| Antares Pharma, Inc. | $61.25 | 4 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $51.36 | 3 | $0 (2020) |
| Myovant Sciences Inc. | $25.73 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.74 | 1 | PROCEPT BioRobotics Corporation ($189.74) |
| 2022 | $30.73 | 2 | Palette Life Sciences, Inc. ($17.33) |
| 2021 | $211.10 | 11 | Laborie Medical Technologies Corp. ($67.57) |
| 2020 | $104.65 | 6 | PFIZER INC. ($26.57) |
| 2019 | $128.62 | 7 | Astellas Pharma US Inc ($61.14) |
| 2018 | $333.34 | 7 | Coloplast Corp ($206.17) |
| 2017 | $144.15 | 3 | C. R. Bard, Inc. & Subsidiaries ($109.55) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $189.74 | General |
| Category: UROLOGY | ||||||
| 01/27/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.33 | General |
| 10/12/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: UROLOGY | ||||||
| 10/05/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Urology | ||||||
| 09/21/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: HORMONE THERAPY | ||||||
| 09/09/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $11.55 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 08/31/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 08/19/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: HORMONE THERAPY | ||||||
| 07/27/2021 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Medical Systems | ||||||
| 07/14/2021 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $67.57 | General |
| 06/15/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: UROLOGY | ||||||
| 03/24/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: UROLOGY | ||||||
| 02/04/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Interventional Urology | ||||||
| 10/09/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/25/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Rheumatoid Arthritis | ||||||
| 01/10/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Interventional Urology | ||||||
| 12/12/2019 | Antares Pharma, Inc. | Otrexup (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Rheumatoid Arthritis | ||||||
| 09/18/2019 | Antares Pharma, Inc. | Otrexup (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Rheumatoid Arthritis | ||||||
| 08/22/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2019 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $48.25 | General |
| 05/01/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,498 | 4,745 | $626,534 | $163,102 |
| 2022 | 32 | 2,319 | 3,194 | $709,687 | $188,957 |
| 2021 | 28 | 1,706 | 3,696 | $573,044 | $147,187 |
| 2020 | 14 | 865 | 1,213 | $296,560 | $68,475 |
Total Patients
7,388
Total Services
12,848
Medicare Billing
$567,721
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 517 | $141,658 | $49,745 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 335 | 413 | $77,644 | $27,620 | 35.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 79 | 89 | $79,210 | $18,483 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $44,084 | $12,982 | 29.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 43 | $21,371 | $6,215 | 29.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 51 | $17,136 | $5,423 | 31.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 39 | 39 | $13,260 | $4,710 | 35.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 24 | 24 | $34,632 | $4,252 | 12.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 67 | $11,993 | $4,220 | 35.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 316 | 441 | $50,715 | $3,839 | 7.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 22 | $8,052 | $3,185 | 39.6% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 1,450 | $7,250 | $3,184 | 43.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 26 | 43 | $18,275 | $2,146 | 11.7% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 13 | 28 | $40,852 | $2,051 | 5.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 157 | 210 | $3,150 | $1,747 | 55.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 76 | 95 | $7,220 | $1,694 | 23.5% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 19 | 19 | $7,391 | $1,610 | 21.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 15 | 16 | $6,059 | $1,472 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,836 | $1,334 | 34.8% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 115 | 155 | $5,115 | $1,226 | 24.0% |
| 87088 | Bacterial urine culture | Office | 2023 | 111 | 151 | $5,134 | $1,197 | 23.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 258 | 360 | $3,600 | $792.00 | 22.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 19 | 19 | $3,819 | $709.03 | 18.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 18 | $1,746 | $702.95 | 40.3% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 25 | 32 | $2,432 | $558.62 | 23.0% |
About Dr. Brian Weiss, M.D
Dr. Brian Weiss, M.D is a Urology healthcare provider based in Linwood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1790046324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Weiss, M.D has received a total of $1,142 in payments from pharmaceutical and medical device companies, with $189.74 received in 2024. These payments were reported across 37 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,142).
As a Medicare-enrolled provider, Weiss has provided services to 7,388 Medicare beneficiaries, totaling 12,848 services with total Medicare billing of $567,721. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Linwood, NJ
- Active Since 05/30/2012
- Last Updated 03/07/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1790046324
Products in Payments
- ALTIS (Device) $206.17
- AQUABEAM SYSTEM (Device) $189.74
- XTANDI (Drug) $113.03
- BMD-Bard Skylite (Device) $109.55
- LITHOVUE (Device) $63.23
- PROVENGE (Drug) $51.36
- MYRBETRIQ (Drug) $40.60
- Otrexup (Drug) $29.55
- ORGOVYX (Drug) $25.73
- XIAFLEX (Biological) $25.62
- UroLift (Device) $20.95
- XYOSTED (Drug) $16.28
- OTREXUP (Drug) $15.42
- UroLift System (Device) $15.14
- GEMTESA (Drug) $15.00
- Prolia (Biological) $14.29
- FIRMAGON (Drug) $13.98
- SPRIX (Drug) $12.76
- Prolaris (Device) $11.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Linwood
David Sussman, D.o, D.O
Urology — Payments: $1.0M
Urology $1.0M
Dr. Thomas Mueller, Md, MD
Urology — Payments: $966,134
Urology $966,134
Michael Bernstein, Md, MD
Urology — Payments: $15,294
Urology $15,294
Sanjay Kasturi, Md, MD
Urology — Payments: $10,197
Urology $10,197
Dr. Roberto Navarrete, Md, MD
Urology — Payments: $9,112
Urology $9,112
Marcella Nachmann, D.o, D.O
Urology — Payments: $8,061
Urology $8,061